经椎间孔经皮内镜下减压治疗下胸椎椎管狭窄
本文回顾性分析了6例因下肢交感症状接受经椎间孔经皮内镜下胸椎减压的下胸椎椎管狭窄患者,评估手术前后Frankel分级、JOA评分、ODI评分及背部和下肢VAS评分。结果显示所有患者术后3个月Frankel分级恢复正常,JOA评分显著升高,ODI和VAS评分显著下降(P<0.05),末次随访时4例优、2例良,表明该技术有效且安全。
要点
- 经椎间孔经皮内镜下减压可改善下胸椎椎管狭窄患者的下肢交感症状。
- 术后JOA评分显著升高,ODI和VAS评分显著下降(P<0.05)。
- 所有患者术后3个月Frankel分级恢复正常,末次随访疗效优4例、良2例。
核心结论
- 经椎间孔经皮内镜下胸椎减压治疗下胸椎椎管狭窄有效且安全。
研究设计与样本
- 回顾性研究,纳入6例因下肢交感症状接受经椎间孔经皮内镜下胸椎减压的下胸椎椎管狭窄患者。
- 评估术前及术后Frankel分级、JOA评分、ODI评分及背部和下肢VAS评分,采用Wilcoxon符号秩检验进行统计分析。
主要发现
- 所有6例患者完成随访,平均随访12.6个月。
- 所有患者Frankel分级在术后第3个月改善至正常。
- JOA评分从术前4.4(范围3.5-5.0)显著升高至术后5.5(范围5.0-6.5)、3个月6.5(范围6.0-7.0)、6个月6.6(范围6.2-7.0)、12个月6.6(范围6.2-7.1)(P<0.05)。
- ODI评分从术前71.2(范围65-78)显著下降至术后50.2(范围45-60)、3个月30.3(范围25-40)、6个月12.2(范围0-20)、12个月10.2(范围0-15)(P<0.05)。
- 背部VAS评分从术前7.8(范围7.0-9.0)显著下降至术后6.9(范围6.0-7.5)、3个月3.3(范围3.0-4.0)、6个月2.3(范围2.0-3.0)、12个月1.9(范围1.5-3.0)(P<0.05);下肢VAS评分从术前8.7(范围8.0-9.0)显著下降至术后3.0(范围2.5-3.6)、3个月1.1(范围0.5-1.3)、6个月0.9(范围0.2-1.2)、12个月0.3(范围0.1-1.0)(P<0.05)。
临床怎么用
- 对于下胸椎椎管狭窄伴下肢交感症状的患者,可考虑采用经椎间孔经皮内镜下减压术。
- 术后应定期评估Frankel分级、JOA评分、ODI评分及VAS评分以监测疗效。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To explore the effect and safety of transforaminal percutaneous endoscopic decompression for lower thoracic spinal stenosis. METHODS: We reviewed 6 patients receiving transforaminal percutaneous endoscopic thoracic decompression for sympathetic symptoms in the lower extremities. Pre- and postoperative Frankel grade and Japanese Orthopaedic Association scale (JOA) score, Oswestry Disability Index (ODI) score, and visual analog scale (VAS) scores of back and lower extremities were also evaluated and recorded. Wilcoxon signed-rank test was performed for statistical analysis. RESULTS: All 6 patients completed the follow-up. Mean follow-up was 12.6 months. Frankel grade in all patients improved to normal at the third month after operation. JOA scores significantly increased from 4.4 (range, 3.5-5.0) preoperatively to 5.5 (range, 5.0-6.5) postoperatively, to 6.5 (range, 6.0-7.0) at 3 months, to 6.6 (range, 6.2-7.0) at 6 months, and to 6.6 (range, 6.2-7.1) at 12 months (P < 0.05). ODI scores significantly decreased from 71.2 (range, 65-78) preoperatively to 50.2 (range, 45-60) postoperatively, to 30.3 (range, 25-40) at 3 months, to 12.2 (range, 0-20) at 6 months, and to 10.2 (range, 0-15) at 12 months (P < 0.05). VAS back scores decreased from 7.8 (range, 7.0-9.0) preoperatively to 6.9 (range, 6.0-7.5) postoperatively, to 3.3 (range, 3.0-4.0) at 3 months, to 2.3 (range, 2.0-3.0) at 6 months, and to 1.9 (range, 1.5-3.0) at 12 months (P < 0.05). VAS lower extremity scores decreased from 8.7 (range, 8.0-9.0) preoperatively to 3.0 (range, 2.5-3.6) postoperatively, to 1.1 (range, 0.5-1.3) at 3 months, to 0.9 (range, 0.2-1.2) at 6 months, and to 0.3 (range, 0.1-1.0) at 12 months (P < 0.05). Four patients reported excellent results and 2 reported good results at the last follow-up. CONCLUSIONS: Percutaneous endoscopic transforaminal thoracic decompression is effective and safe in settling lower thoracic spinal stenosis.
引用
- Guo C, Zhu D, Kong Q, et al. Transforaminal Percutaneous Endoscopic Decompression for Lower Thoracic Spinal Stenosis. World Neurosurg. 2019. PMID: 31051300. doi:10.1016/j.wneu.2019.04.186
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。